Oncogene Cancer Research

Gustavo Viani: Stereotactic Body Radiation Therapy – Does scheduling matter?

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo, shared on X:

“SBRT: Does scheduling Matter?

New data on SBRT scheduling for Stage I NSCLC suggest:
•3 fractions: QOD high survival (aHR = 0.91; P = .02) vs daily
•5 fractions: Daily may be better (aHR = 1.11; P = .02) vs QOD

Why it matters: Scheduling impacts outcomes by balancing tumor control & normal tissue recovery
How do YOU schedule lung SBRT in your practice?”

Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung Cancer

Authors: Yue Lin, Muhammad M. Qureshi, Sonny Batra, Minh-Tam Truong, Kimberley S. Mak

Gustavo Viani: Stereotactic Body Radiation Therapy - Does scheduling matter?

cancer Gustavo Viani Kimberley S Mak Minh Tam Truong Muhammad M. Qureshi OncoDaily Oncology Sonny Batra Yue Lin